Phase I Clinical Trial to Evaluate a Neisseria Gonorrhoeae Therapeutic Candidate
$204,339N01FY2016AINIH
Duke University, Durham NC
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic agents for the treatment of infectious disease.
View original record on NIH RePORTER →